Gainers
-
Aemetis Inc (NASDAQ: AMTX) shares surged 62.36
percent to close at $1.05 on Tuesday following news that the company has completed operation of cellulosic ethanol integrated
demonstration unit.
-
ACM Research Inc (NASDAQ: ACMR) shares jumped
40.04 percent to close at $11.00 on Tuesday.
-
Baozun Inc (ADR) (NASDAQ: BZUN) gained 31.11
percent to close at $48.21 on Tuesday after reporting Q4 results.
-
CommerceHub Inc (NASDAQ: CHUBK) climbed 28.33
percent to close at $22.42 as the company agreed to be acquired by GTCR and Sycamore Partners for $22.75 per share in cash.
-
Clearside BioMedical, Inc. (NASDAQ: CLSD) shares
gained 25.36 percent to close at $12.95. Clearside Biomedical reported offering of $75 million in common stock and announced
the enrollment of its first patient in its TOPAZ study.
-
Zosano Pharma Corporation (NASDAQ: ZSAN) shares
surged 24.56 percent to close at $9.28
-
CommerceHub Inc (NASDAQ: CHUBA) rose 23.15
percent to close at $22.50 as the company agreed to be acquired by GTCR and Sycamore Partners for $22.75 per share in cash.
-
Synthesis Energy Systems, Inc. (NASDAQ: SES)
gained 19.45 percent to close at $3.40.
-
Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) rose
19.15 percent to close at $5.60.
-
Ameresco Inc (NYSE: AMRC) shares gained 18.56
percent to close at $9.90 following upbeat Q4 results.
-
Siebert Financial Corp. (NASDAQ: SIEB) shares
rose 17.76 percent to close at $9.35.
-
Amedica Corporation (NASDAQ: AMDA) shares gained
16.5 percent to close at $2.33 after the company reported the FDA clearance of Valeo C+CsC with Lumen Interbody Fusion Device.
-
SELLAS Life Sciences Group, Inc. (NASDAQ: SLS)
jumped 13.85 percent to close at $6.00.
-
OncoMed Pharmaceuticals, Inc. (NASDAQ: OMED)
gained 13.73 percent to close at $2.90 on Tuesday.
-
American Public Education, Inc. (NASDAQ: APEI)
shares climbed 13.26 percent to close at $40.15.
-
CRH Medical Corporation (NYSE: CRHM) gained 12.07
percent to close at $3.25 following Q4 results.
-
Anavex Life Sciences Corp. (NASDAQ: AVXL) shares
jumped 11.83 percent to close at $2.93 on Tuesday.
-
Analogic Corporation (NASDAQ: ALOG) shares rose
10.54 percent to close at $93.90 following strong Q2 results.
-
Ciena Corporation (NYSE: CIEN) climbed 10.06
percent to close at $25.71 after the company reported better-than-expected results for its first quarter.
-
Frontline Ltd. (NYSE: FRO) shares climbed 9.9
percent to close at $4.44.
-
Sunshine Heart Inc (NASDAQ: CHFS) shares gained
9.01 percent to close at $3.51.
-
Caladrius Biosciences Inc (NASDAQ: CLBS) gained
8.95 percent to close at $5.48. Caladrius Biosciences acquired a license to a late stage CD34+ cell therapy program for the
treatment of refractory angina from Shire.
-
DURECT Corporation (NASDAQ: DRRX) gained 8.67
percent to close at $1.63. H.C. Wainwright upgraded DURECT from Neutral to Buy.
-
Par Pacific Holdings, Inc. (NYSE: PARR) gained 7.51
percent to close at $18.61 after reporting Q4 results.
-
Quanex Building Products Corporation (NYSE: NX)
gained 6.02 percent to close at $18.50 following upbeat quarterly results.
-
Baytex Energy Corp (USA) (NYSE: BTE) gained 4.74
percent to close at $2.87 after reporting 2017 results.
Check out these big penny stock gainers and
losers
Losers
-
Lianluo Smart Limited (NASDAQ: LLIT) shares
dipped 20.34 percent to close at $2.31.
-
GlycoMimetics Inc (NASDAQ: GLYC) tumbled 17.84
percent to close at $18.75 on Tuesday after reporting the design of phase 3 trial of GMI-1271 in relapsed/refractory AML.
GlycoMimetics reported a Q4 loss of $0.27 per share.
-
Infinity Pharmaceuticals Inc. (NASDAQ: INFI)
shares fell 17.28 percent to close at $2.25 on Tuesday after rising 31.40 percent on Monday.
-
Innovate Biopharmaceuticals Inc (NASDAQ: INNT)
shares fell 16.18 percent to close at $14.50 on Tuesday after rising 82.49 percent on Monday.
-
TransAct Technologies Incorporated (NASDAQ: TACT)
shares fell 13.87 percent to close at $11.80 following a fourth quarter earnings and sales miss. The company also announced a
$5 million share buyback plan.
-
Marinus Pharmaceuticals Inc (NASDAQ: MRNS) shares
slipped 13.71 percent to close at $4.53. Marinus Pharma reported a FY 2017 loss of $0.80 per share.
-
Orchids Paper Products Company (NYSE: TIS) shares
fell 12.56 percent to close at $9.40 after the company reported downbeat quarterly results.
-
YY Inc (ADR) (NASDAQ: YY) dropped 12.3 percent to
close at $118.76 following quarterly results.
-
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH)
fell 12.1 percent to close at $24.27.
-
Allied Healthcare Products, Inc. (NASDAQ: AHPI)
dropped 10.55 percent to close at $3.39.
-
Freshpet Inc (NASDAQ: FRPT) declined 10.09
percent to close at $18.50 following Q4 earnings miss and soft FY18 sales guidance.
-
Boston Omaha Corporation (NASDAQ: BOMN) dropped
9.81 percent to close at $23.35.
-
Ares Management LP (NYSE: ARES) fell 9.5 percent to
close at $22.85 following news of 5 million share offering by the company and 10 million share offering by strategic investor.
-
Reata Pharmaceuticals, Inc. (NASDAQ: RETA)
dropped 9.25 percent to close at $20.99 on Tuesday.
-
MGP Ingredients, Inc. (NASDAQ: MGPI) fell 8.82
percent to close at $75.91.
-
Ascena Retail Group Inc (NASDAQ: ASNA) shares
fell 6 percent to close at $2.275 after the company posted a wider-than-expected loss for its second quarter and issued weak
third-quarter earnings guidance.
-
Fate Therapeutics Inc (NASDAQ: FATE) fell 5.16
percent to close at $13.06. Fate Therapeutics reported a Q4 loss of $0.29 per share.
-
Target Corporation (NYSE: TGT) shares fell 4.46
percent to close at $71.79 after the company reported downbeat earnings for its fourth quarter.
© 2018 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.